These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3140398)

  • 1. [Immunoblastic lymphoma as the terminal phase of an IgG myeloma].
    Romero MS; Puente F; Soria J; Gutiérrez M
    Sangre (Barc); 1988 Jun; 33(3):240-1. PubMed ID: 3140398
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant B cell immunoblastic lymphoma expressing CD30 antigen in the terminal phase of a multiple myeloma.
    Castrillo JM; Rivas C; Alonso C; Varela A; Gonzalo A; Jimenéz-Casado M
    Appl Pathol; 1989; 7(6):375-81. PubMed ID: 2561814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant plasmoblastic lymphoma with monoclonal IgG kappa immunoglobulin and detectable immunoglobulin C-delta genes].
    Hauke G; Epplen JT; Hinkkanen A; Freudenberg N; Köchling G; Peter HH
    Med Klin (Munich); 1988 Mar; 83(7):246-50. PubMed ID: 3132594
    [No Abstract]   [Full Text] [Related]  

  • 4. Triclonal gammopathy in an extranodal non-Hodgkin lymphoma patient.
    Tirelli A; Guastafierro S; Cava B; Lucivero G
    Am J Hematol; 2003 Aug; 73(4):273-5. PubMed ID: 12879432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nodular lymphoma with monoclonal proteins in the serum, IgG lambda myeloma and immunoblastic B-cell sarcoma in the same patient. Proliferation from a single cellular clone].
    Coma Luengo MA; Luño E; Carrera D; Ordóñez A; Fernández C; Fresno M
    Sangre (Barc); 1986; 31(1):72-82. PubMed ID: 3085243
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific cutaneous localizations of myeloma].
    Andry P; Bodemer C; Teillac D; Guérin V; de Prost Y
    Ann Dermatol Venereol; 1991; 118(11):887-8. PubMed ID: 1789672
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous manifestations of multiple myeloma.
    Sirot G
    Cutis; 1979 Feb; 23(2):174-7. PubMed ID: 105833
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of B-cell in peripheral blood and skin tumor of IgG kappa type myeloma (author's transl)].
    Yoshinaga H; Matsuo T; Yamamoto Y; Hurukawa H
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):665-70. PubMed ID: 6809990
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaplastic plasma cell myeloma and immunoblastic lymphoma. Clinical, pathologic, and immunologic comparison.
    Strand WR; Banks PM; Kyle RA
    Am J Med; 1984 May; 76(5):861-7. PubMed ID: 6547021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of multiple myeloma with double M-protein peaks for IgG-kappa and IgA-kappa].
    Tadao F; Hayashi M; Ichikawa K; Hirasawa Y; Ohtani H; Saito M; Hatimura K; Oshikawa T; Takayama M; Mori N
    Rinsho Ketsueki; 1984 Oct; 25(10):1646-52. PubMed ID: 6441031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual case of myeloma. Non-secretory IgD-kappa myeloma with de-differentiation of kappa myeloma evolving from solitary plasmocytoma.
    Nelis GF
    Acta Med Scand; 1982; 211(1-2):141-4. PubMed ID: 6803520
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gross spreading multiple extramedullary plasmacytomas to the skin in the terminal stage of multiple myeloma].
    Kanno M; Nakamura S; Danno D; Uotani C; Kotani T; Yamanaka S; Terasaki Y; Matano S; Okumura H
    Rinsho Ketsueki; 2001 Jul; 42(7):554-8. PubMed ID: 11524846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three M-components IgA lambda + IgG kappa n + IgG kappa h in one patient (DA): lack of shared idiotypic determinants between IgA and IgG, and the presence of an unusual kappa h chain of 30,000 M.W.
    Bouvet JP; Liacopoulos P; Pillot J; Banda R; Tung E; Wang AC
    J Immunol; 1980 Jul; 125(1):213-20. PubMed ID: 6769997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vortex keratopathy in a patient with multiple myeloma.
    Chong EM; Campbell RJ; Bourne WM
    Cornea; 1997 Sep; 16(5):592-4. PubMed ID: 9294696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma first observed as multiple cutaneous plasmacytomas.
    Shah A; Klimo P; Worth A
    Arch Dermatol; 1982 Nov; 118(11):922-4. PubMed ID: 6814367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T-lymphocyte lymphoma in association with multiple myeloma.
    Weiss VC; Barsky GJ; Solomon LM
    Arch Dermatol; 1984 Apr; 120(4):499-501. PubMed ID: 6608320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoblastic sarcoma in an IgM myeloma with the appearance of a second monoclonal component].
    Juliá A; Zuazu J; Ruiz-Marcellán C
    Sangre (Barc); 1985; 30(3):355-62. PubMed ID: 3929411
    [No Abstract]   [Full Text] [Related]  

  • 20. [Two-peak monoclonal protein (IgA kappa and IgG kappa) in non-Hodgkin lymphoma].
    Yoda Y; Ito T; Inoue S; Mori N; Nakazawa M; Kato K
    Rinsho Ketsueki; 1997 May; 38(5):433-9. PubMed ID: 9194389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.